Glenn Kerner, head of the Litigation Department in Goodwin’s New York office, has extensive experience in products liability law, particularly with respect to complex mass torts and multi-district litigation (MDL). Mr. Kerner is experienced in matters involving pharmaceuticals and medical devices, food and dietary supplements, consumer products and chemical exposure. He also has experience in complex commercial litigation, franchise law, bankruptcy litigation, real estate litigation, antitrust, intellectual property, and other civil litigation.
Mr. Kerner has played a major role in some of the most hotly-contested and high-profile mass torts and MDLs in the past 20 years. In the area of pharmaceuticals, Mr. Kerner has litigated mass torts and MDLs involving alendronate, where he was appointed by the Federal Judge as liaison counsel for the generic pharmaceutical defendants, amiodarone, metoclopramide, pamidronate, propofol, PPA and the diet drug fen-phen. Other mass torts and MDLs in which Mr. Kerner has been actively involved include ephedra, natural rubber latex gloves, orthopedic bone screws and semiconductor clean rooms. He has successfully litigated individual cases concerning various consumer products, as well as pharmaceuticals and orthopedic medical devices. Mr. Kerner has acted as lead trial counsel in cases across multiple industries and jurisdictions. In his role as national counsel, Mr. Kerner supervises local counsel and is responsible for coordinating and maintaining a consistent litigation strategy on a nationwide basis. He works closely with a national network of medical, scientific, regulatory and industry experts in preparation for trials and Daubert hearings.
Mr. Kerner also provides strategic counseling to clients on litigation avoidance and risk management in various industries. He advises clients on labeling and warnings issues, including regulatory compliance.
Mr. Kerner is the Chair of the Food Law Special Litigation Group of the Defense Research Institute (DRI) Product Liability Committee and is the Past Chair of the Class Action and Mass Tort Special Litigation Group of the DRI's Product Liability Committee. He also serves on DRI’s Product Liability Steering Committee and is also the Chair of the firm’s Nanotechnology Practice.
Mr. Kerner has been recognized in The Legal 500 U.S., Best Lawyers and Super Lawyers and is listed in Chambers USA: America’s Leading Lawyers for Business.
While attending law school at Fordham University School of Law, he was a member of the International Law Journal.
Mr. Kerner speaks, lectures and writes frequently on such topics as mass torts, food, drugs and medical devices.
His recent presentations include:
Among the many publications he has authored and co-authored, the most recent include:
Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。